Education
About Us
Working with TipRanks
Follow Us
Lumos Diagnostics Holdings Ltd. (AU:LDX)
ASX:LDX
RESEARCH TOOLSreports
Total Valuation
Lumos Diagnostics Holdings Ltd. has a market cap or net worth of AU$22.46M. The enterprise value is AU$8.38M.
Market CapAU$22.46M
Enterprise ValueAU$8.38M
Share Statistics
Lumos Diagnostics Holdings Ltd. has 748,523,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding748,523,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lumos Diagnostics Holdings Ltd.’s return on equity (ROE) is -1.21 and return on invested capital (ROIC) is -46.95%.
Return on Equity (ROE)-1.21
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-46.95%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.41
Inventory Turnover5.14
Valuation Ratios
The current PE Ratio of Lumos Diagnostics Holdings Ltd. is -1.15. Lumos Diagnostics Holdings Ltd.’s PEG ratio is <0.01.
PE Ratio-1.15
PS Ratio0.00
PB Ratio0.17
Price to Fair Value1.39
Price to FCF-0.16
Price to Operating Cash Flow-0.17
PEG Ratio<0.01
Income Statement
In the last 12 months, Lumos Diagnostics Holdings Ltd. had revenue of 11.13M and earned -8.59M in profits. Earnings per share was -0.02.
Revenue11.13M
Gross Profit7.10M
Operating Income-7.12M
Pretax Income-8.59M
Net Income-8.59M
EBITDA-5.44M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -529.00K and capital expenditures -60.00K, giving a free cash flow of -589.00K billion.
Operating Cash Flow-529.00K
Free Cash Flow-589.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Lumos Diagnostics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-5.54
52-Week Price Change0.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)90.35
Average Volume (3m)628.53K
Important Dates
Lumos Diagnostics Holdings Ltd. upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
Lumos Diagnostics Holdings Ltd. as a current ratio of 0.76, with Debt / Equity ratio of 103.02%
Current Ratio0.76
Quick Ratio0.69
Debt to Market Cap0.00
Net Debt to EBITDA-0.29
Interest Coverage Ratio-7.30
Taxes
In the past 12 months, Lumos Diagnostics Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lumos Diagnostics Holdings Ltd. EV to EBITDA ratio is -2.11, with an EV/FCF ratio of 13.50.
EV to Sales1.03
EV to EBITDA-2.11
EV to Free Cash Flow13.50
EV to Operating Cash Flow12.11
Balance Sheet
Lumos Diagnostics Holdings Ltd. has AU$5.53M in cash and marketable securities with $7.81M in debt, giving a net cash position of AU$2.27M billion.
Cash & Marketable SecuritiesAU$5.53M
Total Debt$7.81M
Net CashAU$2.27M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 56.69%, with operating margin of -63.98%, and net profit margin of -77.19%.
Gross Margin56.69%
Operating Margin-63.98%
Pretax Margin-77.19%
Net Profit Margin-77.19%
EBITDA Margin-48.84%
EBIT Margin-72.63%
Analyst Forecast
The average price target for Lumos Diagnostics Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast80.84%
EPS Growth Forecast57.59%